Varicose veins of the great saphenous vein
Conditions
Interventions
Experimental group:In this study, the initial dose of oxyryzine was set at 0.02mg/kg, and the ratio of adjacent drug doses was 1.0:1.1. If a positive body movement reaction occurred during the operati
if it was a negative reaction, a randomization of dosage would be conducted, and there was an 89% probability that the dose of oxyryzine would remain unchanged and a 11% probability that it would be i
Sponsors
Anqing Municipal Hospital
Eligibility
Sex/Gender
All
Age
65 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age range: 65 - 80 years old; 2. ASA classification: I - III; 3. Patients scheduled to undergo radiofrequency ablation surgery for varicose veins of the great saphenous vein; 4. Voluntary participants in this study and who have signed the informed consent form;
Exclusion criteria
Exclusion criteria: 1. History of abuse of sedative and analgesic drugs; 2. Allergy or intolerance to anesthetic drugs; 3. Patients with hearing or speech impairments who are unable to communicate; 4. Preoperative severe cardiopulmonary dysfunction, liver and kidney dysfunction, uncontrolled hypertension, diabetes or other organ dysfunction; 5. Patients or their family members refuse to participate in the study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive motor response; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions such as dizziness, nausea and vomiting occurred 24 hours after the operation.;The number of rescue analgesic administrations 24 hours after the operation;Time to get out of bed;Surgery time;Wake-up time;General information (including age, sex, BMI, ASA classification);Oseltamivir fixed dose, total dose of Remazolam; | — |
Countries
China
Contacts
Public ContactXing Wang
Anqing Municipal Hospital
Outcome results
None listed